TrialAlimentary pharmacology & therapeutics2022

Sofosbuvir and risk of estimated glomerular filtration rate decline or end-stage renal disease in patients with renal impairment.

Mark Sulkowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.